Literature DB >> 21838575

Chronic hyperhomocysteinemia causes vascular remodelling by instigating vein phenotype in artery.

Poulami Basu1, Natia Qipshidze, Utpal Sen, Srikanth Givvimani, Charu Munjal, Paras K Mishra, Suresh C Tyagi.   

Abstract

In the present study we tested the hypothesis whether hyperhomocysteinemia, an elevated homocysteine level, induces venous phenotype in artery. To test our hypothesis, we employed wild type (WT) and cystathionine β-synthase heterozygous (+/-) (CBS+/-) mice treatment with or without folic acid (FA). Aortic blood flow and velocity were significantly lower in CBS+/-mice compared to WT. Aortic lumen diameter was significantly decreased in CBS+/-mice, whereas FA treatment normalized it. Medial thickness and collagen were significantly increased in CBS+/-aorta, whereas elastin/collagen ratio was significantly decreased. Superoxide and gelatinase activity was significantly high in CBS+/-aorta vs WT. Western blot showed significant increase in MMP-2, -9,-12, TIMP-2 and decrease in TIMP-4 in aorta. RT-PCR revealed significant increase of vena cava marker EphB4, MMP-13 and TIMP-3 in aorta. We summarize that chronic HHcy causes vascular remodelling that transduces changes in vascular wall in a way that artery expresses vein phenotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21838575      PMCID: PMC3235642          DOI: 10.3109/13813455.2011.599844

Source DB:  PubMed          Journal:  Arch Physiol Biochem        ISSN: 1381-3455            Impact factor:   4.076


  60 in total

1.  Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort.

Authors:  P F Jacques; A G Bostom; P W Wilson; S Rich; I H Rosenberg; J Selhub
Journal:  Am J Clin Nutr       Date:  2001-03       Impact factor: 7.045

2.  Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial.

Authors:  Jane M Armitage; Louise Bowman; Robert J Clarke; Karl Wallendszus; Richard Bulbulia; Kazem Rahimi; Richard Haynes; Sarah Parish; Peter Sleight; Richard Peto; Rory Collins
Journal:  JAMA       Date:  2010-06-23       Impact factor: 56.272

3.  Hydrogen sulfide regulates homocysteine-mediated glomerulosclerosis.

Authors:  Utpal Sen; Charu Munjal; Natia Qipshidze; Oluwasegun Abe; Riyad Gargoum; Suresh C Tyagi
Journal:  Am J Nephrol       Date:  2010-04-16       Impact factor: 3.754

4.  Functional consequences of the collagen/elastin switch in vascular remodeling in hyperhomocysteinemic wild-type, eNOS-/-, and iNOS-/- mice.

Authors:  Mesia M Steed; Neetu Tyagi; Utpal Sen; Dale A Schuschke; Irving G Joshua; Suresh C Tyagi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-06-25       Impact factor: 5.464

5.  Furin and membrane type-1 metalloproteinase mRNA levels and activation of metalloproteinase-2 are associated with arterial remodeling.

Authors:  D P de Kleijn; J P Sluijter; J Smit; E Velema; W Richard; A H Schoneveld; G Pasterkamp; C Borst
Journal:  FEBS Lett       Date:  2001-07-13       Impact factor: 4.124

6.  Folic acid improves acetylcholine-induced vasoconstriction of coronary vessels isolated from hyperhomocysteinemic mice: an implication to coronary vasospasm.

Authors:  Natia Qipshidze; Naira Metreveli; David Lominadze; Suresh C Tyagi
Journal:  J Cell Physiol       Date:  2011-10       Impact factor: 6.384

7.  Homocysteine-dependent endothelial dysfunction induced by renal ischemia/reperfusion injury.

Authors:  Yagnik S Bhalodia; Navin R Sheth; Jitendra D Vaghasiya; Nurudin P Jivani
Journal:  J Nephrol       Date:  2011 Sep-Oct       Impact factor: 3.902

8.  Cystathionine β-synthase and cystathionine γ-lyase double gene transfer ameliorate homocysteine-mediated mesangial inflammation through hydrogen sulfide generation.

Authors:  Utpal Sen; Srikanth Givvimani; Oluwasegun A Abe; Eleanor D Lederer; Suresh C Tyagi
Journal:  Am J Physiol Cell Physiol       Date:  2010-10-13       Impact factor: 4.249

9.  Overexpression of dimethylarginine dimethylaminohydrolase protects against cerebral vascular effects of hyperhomocysteinemia.

Authors:  Roman N Rodionov; Hayan Dayoub; Cynthia M Lynch; Katina M Wilson; Jeff W Stevens; Daryl J Murry; Masumi Kimoto; Erland Arning; Teodoro Bottiglieri; John P Cooke; Gary L Baumbach; Frank M Faraci; Steven R Lentz
Journal:  Circ Res       Date:  2009-12-17       Impact factor: 17.367

10.  Blood flow interplays with elastin: collagen and MMP: TIMP ratios to maintain healthy vascular structure and function.

Authors:  Poulami Basu; Utpal Sen; Neetu Tyagi; Suresh C Tyagi
Journal:  Vasc Health Risk Manag       Date:  2010-04-15
View more
  4 in total

Review 1.  Cystathionine-β-Synthase: Molecular Regulation and Pharmacological Inhibition.

Authors:  Karim Zuhra; Fiona Augsburger; Tomas Majtan; Csaba Szabo
Journal:  Biomolecules       Date:  2020-04-30

2.  Effect of elastin-derived peptides on the production of tissue inhibitor of metalloproteinase-1, -2, and -3 and the ratios in various endothelial cell lines.

Authors:  Krzysztof Siemianowicz; Wirginia Likus; Tomasz Francuz; Wojciech Garczorz
Journal:  Exp Ther Med       Date:  2015-04-17       Impact factor: 2.447

3.  Dietary methionine restriction in mice elicits an adaptive cardiovascular response to hyperhomocysteinemia.

Authors:  Gene P Ables; Amadou Ouattara; Thomas G Hampton; Diana Cooke; Frantz Perodin; Ines Augie; David S Orentreich
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

4.  Influence of Dietary Supplementation for Hyperhomocysteinemia Treatments.

Authors:  Alessandra Vezzoli; Cinzia Dellanoce; Teresa Maria Caimi; Daniele Vietti; Michela Montorsi; Simona Mrakic-Sposta; Roberto Accinni
Journal:  Nutrients       Date:  2020-06-30       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.